Medicare Part D plans are changing for 2025 – here’s what patients need to know

January brought important changes for the roughly 53 million seniors enrolled in Medicare prescription drug plans. Some of these changes are automatic, while others require patients to proactively enroll. Patients who participated in open enrollment (Oct. …

Is Medicare Free?

Medicare aims to help older adults and those with certain health conditions fund healthcare costs, but it is not completely free. Image for illustration purposes Medical News Today Medicare aims to help older adults and those with certain health conditions …

CMS selects Ozempic, 14 other drugs for Medicare price negotiations

CMS has named 15 additional prescription drugs, including diabetes medication Ozempic, for price negotiations under the Inflation Reduction Act. This marks the second round of negotiations aimed at reducing drug costs for Medicare beneficiaries.  The …

MedRhythms earns Medicare win for stroke gait impairment treatment

The InTandem system in use. [Image courtesy of MedRhythms]MedRhythms announced that it received a final pricing determination from CMS for its InTandem rehabilitation system. InTandem delivers individualized, progressive rhythmic auditory stimulation (RAS) …

STAT+: Pharmalittle: We’re reading about Medicare plans to negotiate obesity-drug prices, a Novartis 340B lawsuit, and ...

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is still shaping up but we do know that we will be catching up on our reading, …

STAT+: Medicare announces plan to negotiate prices of diabetes, weight loss drugs

WASHINGTON — Medicare officials announced plans to negotiate the prices of blockbuster diabetes and weight loss drugs Ozempic and Wegovy, further complicating big decisions the Trump administration will have to make about how to cover the medications. The …

Latest Medicare price drug negotiations includes Ozempic, Wegovy

HHS: Ozempic, Wegovy will be part of Medicare Part D drug price negotiations this year

Ozempic (semaglutide), the Type 2 diabetes drug that has become popular for weight loss, and Wegovy, the form of the drug approved for patients to shed pounds, are on the list for Medicare drug price negotiations in 2025. Rybelsus, the oral form of …

FDA bans Red Dye No. 3; doctor sentenced for $70 million Medicare fraud scheme; last call for proposals for the 2025 CMS ...

FDA bans FD&C Red No. 3 The U.S. Food and Drug Administration (FDA) issued an order to revoke the authorization for the use of FD&C Red No. 3 (also referred to as Red Dye No. 3, Red Dye 3 and erythrosine) in food and ingested drugs, based on the …

HHS Announces Next 15 Drugs for Medicare Part D Price Negotiations

The US Department of Health and Human Services (HSS), through the Centers for Medicare & Medicaid Services, announced the 15 additional drugs for price negotiations under Medicare Part D. As per the Inflation Reduction Act, the negotiations with the …